How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

LCA-0321 is a novel targeted protein degrader designed to specifically and rapidly eliminate TSHR autoantibodies for the treatment of Graves’ disease

calendar_today November 5, 2026 person production domain lycia-therapeutics

The post LCA-0321 is a novel targeted protein degrader designed to specifically and rapidly eliminate TSHR autoantibodies for the treatment of Graves’ disease appeared first on Lycia Therapeutics .

open_in_new Read original post